Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
1.19
Dollar change
+0.03
Percentage change
2.59
%
Index- P/E- EPS (ttm)-1.59 Insider Own51.37% Shs Outstand41.49M Perf Week12.26%
Market Cap49.37M Forward P/E- EPS next Y-1.32 Insider Trans0.00% Shs Float20.18M Perf Month19.00%
Income-66.97M PEG- EPS next Q-0.29 Inst Own27.96% Short Float1.82% Perf Quarter7.21%
Sales0.60M P/S82.28 EPS this Y22.83% Inst Trans-3.78% Short Ratio5.17 Perf Half Y-27.44%
Book/sh1.71 P/B0.70 EPS next Y6.90% ROA-63.12% Short Interest0.37M Perf Year-58.82%
Cash/sh1.81 P/C0.66 EPS next 5Y- ROE-68.90% 52W Range0.95 - 3.46 Perf YTD-50.21%
Dividend Est.- P/FCF- EPS past 5Y-35.52% ROI-94.57% 52W High-65.61% Beta-1.55
Dividend TTM- Quick Ratio9.55 Sales past 5Y0.00% Gross Margin77.09% 52W Low25.26% ATR (14)0.08
Dividend Ex-Date- Current Ratio9.55 EPS Y/Y TTM11.75% Oper. Margin-11705.69% RSI (14)63.21 Volatility8.52% 7.83%
Employees43 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin-11199.50% Recom1.00 Target Price8.25
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q43.28% Payout- Rel Volume2.40 Prev Close1.16
Sales Surprise298.67% EPS Surprise26.14% Sales Q/Q- EarningsNov 07 BMO Avg Volume70.97K Price1.19
SMA2011.87% SMA5011.90% SMA200-14.52% Trades Volume170,273 Change2.59%
Date Action Analyst Rating Change Price Target Change
May-15-24Downgrade JP Morgan Overweight → Neutral
Feb-07-24Downgrade Jefferies Buy → Hold $7 → $1.50
Apr-17-23Initiated H.C. Wainwright Buy $18
Apr-10-23Initiated Wedbush Outperform $17
Dec-09-22Initiated JP Morgan Overweight $21
Feb-22-22Initiated JMP Securities Mkt Outperform $32
Aug-23-21Initiated Jefferies Buy $20
Aug-23-21Initiated Evercore ISI Outperform $40
Aug-23-21Initiated Cowen Outperform
Dec-10-24 08:00AM
Dec-06-24 06:48AM
Dec-02-24 08:00AM
Nov-27-24 08:00AM
Nov-26-24 08:00AM
08:00AM Loading…
Nov-25-24 08:00AM
Nov-22-24 07:01AM
Nov-21-24 08:00AM
Nov-07-24 08:00AM
Nov-05-24 02:59AM
Oct-29-24 08:00AM
Sep-30-24 08:00AM
Sep-23-24 08:00AM
Sep-10-24 08:00AM
Sep-09-24 05:15PM
08:00AM Loading…
Aug-29-24 08:00AM
Aug-27-24 08:00AM
Aug-14-24 12:00PM
Aug-08-24 08:00AM
Jul-09-24 08:00AM
Jun-17-24 08:00AM
May-31-24 07:00AM
May-10-24 06:30AM
May-09-24 01:54PM
10:14AM
08:00AM
May-07-24 08:00AM
Apr-17-24 04:01PM
Apr-12-24 10:23AM
Apr-11-24 07:43AM
04:01PM Loading…
Apr-10-24 04:01PM
01:01PM
Apr-01-24 10:05AM
Mar-12-24 08:00AM
Feb-26-24 08:00AM
Feb-06-24 09:46AM
08:00AM
Jan-04-24 08:00AM
Dec-20-23 08:00AM
Dec-09-23 12:00PM
Nov-28-23 07:00AM
Nov-09-23 08:00AM
Nov-08-23 08:00AM
Nov-02-23 09:15AM
Oct-03-23 08:00AM
Sep-03-23 12:00PM
Aug-31-23 08:00AM
Aug-08-23 08:00AM
Aug-02-23 08:00AM
Jul-11-23 08:00AM
Jun-29-23 07:00AM
Jun-24-23 03:30PM
Jun-09-23 09:15AM
Jun-01-23 08:00AM
May-29-23 09:55AM
May-12-23 09:55AM
May-09-23 08:00AM
May-08-23 08:00AM
Apr-06-23 08:00AM
Apr-03-23 08:00AM
Mar-15-23 09:15AM
Mar-10-23 09:35AM
Mar-06-23 02:49PM
08:00AM
07:30AM
Mar-02-23 09:01AM
Mar-01-23 08:00AM
Feb-27-23 07:00AM
Jan-31-23 04:05PM
Jan-05-23 08:00AM
Dec-15-22 08:00AM
Dec-14-22 06:39AM
Dec-12-22 05:55PM
Dec-01-22 07:00AM
Nov-29-22 08:00AM
Nov-17-22 05:39AM
Nov-11-22 08:00AM
Nov-10-22 11:51PM
09:15AM
Nov-07-22 08:00AM
07:30AM
Oct-06-22 08:38AM
Sep-28-22 12:37PM
08:00AM
Aug-31-22 08:00AM
Aug-08-22 08:00AM
Aug-02-22 08:00AM
Jul-06-22 07:37AM
Jun-02-22 08:30AM
Jun-01-22 08:00AM
May-10-22 08:00AM
07:30AM
Apr-29-22 08:36AM
Apr-28-22 11:45AM
Apr-04-22 08:00AM
Mar-15-22 08:00AM
Feb-28-22 08:00AM
Jan-27-22 08:49AM
Jan-18-22 08:00AM
Jan-06-22 08:00AM
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.